8-KLeadership ChangesRegulation FDExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Executive Changes (Jun 26, 2020)

Filed June 26, 2020For Securities:CAH

Summary

Cardinal Health, Inc. (CAH) announced a key leadership change through an 8-K filing on June 26, 2020. The company's Board of Directors elected David C. Evans to the Board, effective July 1, 2020. Mr. Evans brings extensive financial leadership experience, having previously served as EVP and CFO for Battelle Memorial Institute and The Scotts Miracle-Gro Company. Notably, he also served as Cardinal Health's interim Chief Financial Officer from September 2019 to May 2020, providing a seamless transition and demonstrating his familiarity with the company's operations. This appointment is significant as Mr. Evans has been deemed independent by the Board, meeting New York Stock Exchange and the Company's Corporate Governance Guidelines. His inclusion on the Board is expected to strengthen financial oversight and strategic guidance. Mr. Evans will participate in the standard non-management director compensation program and will receive a prorated grant of restricted share units based on his start date.

Key Highlights

  • 1David C. Evans appointed to the Board of Directors, effective July 1, 2020.
  • 2Mr. Evans previously served as Cardinal Health's interim Chief Financial Officer (September 2019 - May 2020).
  • 3Extensive financial expertise with prior CFO roles at Battelle Memorial Institute and The Scotts Miracle-Gro Company.
  • 4Mr. Evans has been determined to be independent under NYSE and company guidelines.
  • 5Will participate in non-management director compensation arrangements.
  • 6Receives a prorated initial grant of $65,384 in restricted share units.
  • 7Appointment aims to enhance Board's financial oversight and strategic input.

Frequently Asked Questions